Growth Metrics

TriSalus Life Sciences (TLSI) Return on Assets (2022 - 2026)

TriSalus Life Sciences has reported Return on Assets over the past 5 years, most recently at 0.01% for Q1 2026.

  • For Q1 2026, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM value through Mar 2026 reached 0.01%, up 1.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Assets for Q1 2026 was 0.01% at TriSalus Life Sciences, up from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q3 2022 and troughed at 0.03% in Q2 2023.
  • A 5-year average of 0.01% and a median of 0.01% in 2024 define the central range for Return on Assets.
  • Biggest five-year swings in Return on Assets: fell -2bps in 2023 and later grew 2bps in 2025.
  • Year by year, Return on Assets stood at 0.0% in 2022, then plummeted by -997bps to 0.02% in 2023, then skyrocketed by 43bps to 0.01% in 2024, then grew by 6bps to 0.01% in 2025, then surged by 53bps to 0.01% in 2026.
  • Business Quant data shows Return on Assets for TLSI at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.